Ottawa, Canada

Jianbing Zhang

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Jianbing Zhang

Introduction

Jianbing Zhang is a prominent inventor based in Ottawa, Canada, known for his significant contributions to the field of protein engineering. With a total of seven patents to his name, Zhang has made remarkable strides in developing therapeutic proteins and antibodies that have the potential to address critical health issues.

Latest Patents

Zhang's latest patents include innovative methods for screening protein candidates. His invention focuses on the simultaneous evaluation of expression levels, biophysical properties, and affinities of protein candidates. This method involves fusing protein candidates to a protein anchor, which is then captured by a target or antigen. The captured proteins are assessed using conventional methods to determine their suitability for therapeutic applications. Another notable patent describes single domain antibodies that bind to PCSK9, which are crucial for lowering low-density lipoprotein-cholesterol (LDL-C) levels. This invention has implications for treating cardiovascular disorders, showcasing Zhang's commitment to advancing medical science.

Career Highlights

Throughout his career, Jianbing Zhang has worked with esteemed organizations, including the National Research Council of Canada and Adaerata Limited Partnership. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects, further enhancing his expertise in protein engineering.

Collaborations

Zhang has collaborated with notable colleagues such as C Roger MacKenzie and Tomoko Hirama. These partnerships have contributed to

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…